{"id":"https://openalex.org/W1854929367","doi":"https://doi.org/10.64719/pb.4089","title":"A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder","display_name":"A Systematic Review of Augmentation Strategies for Patients with Major Depressive Disorder","publication_year":2025,"publication_date":"2025-08-12","ids":{"openalex":"https://openalex.org/W1854929367","doi":"https://doi.org/10.64719/pb.4089","mag":"1854929367","pmid":"https://pubmed.ncbi.nlm.nih.gov/19752841"},"language":"en","primary_location":{"id":"doi:10.64719/pb.4089","doi":"https://doi.org/10.64719/pb.4089","is_oa":false,"landing_page_url":"https://doi.org/10.64719/pb.4089","pdf_url":null,"source":{"id":"https://openalex.org/S5407052355","display_name":"Psychopharmacology Bulletin","issn_l":"0048-5764","issn":["0048-5764","2472-2448"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology Bulletin","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048523867","display_name":"Rachael Fleurence","orcid":"https://orcid.org/0000-0002-3526-1732","observed_orcids":["https://orcid.org/0000-0002-3526-1732"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rachael Fleurence","raw_affiliation_strings":["Center for Health Economics and Science Policy, United BioSource Corporation, Bethesda, MD, USA","Center for Health Economics and Science Policy, United BioSource Corporation, Bethesda, MD, USA. rachael.fleurence@unitedbiosource.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Health Economics and Science Policy, United BioSource Corporation, Bethesda, MD, USA","institution_ids":[]},{"raw_affiliation_string":"Center for Health Economics and Science Policy, United BioSource Corporation, Bethesda, MD, USA. rachael.fleurence@unitedbiosource.com","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Rebecca Williamson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rebecca Williamson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111492264","display_name":"Yonghua Jing","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yonghua Jing","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100728162","display_name":"Edward Kim","orcid":"https://orcid.org/0000-0001-8247-6675","observed_orcids":["https://orcid.org/0000-0001-8247-6675"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward Kim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109973603","display_name":"Quynh-Van Tran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Quynh-Van Tran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111956671","display_name":"Andrei Pikalov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrei Pikalov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103401991","display_name":"Michael E. Thase","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael E. Thase","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.2604,"has_fulltext":false,"cited_by_count":64,"citation_normalized_percentile":{"value":0.75238767,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"42","issue":"3","first_page":"57","last_page":"91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10854","display_name":"Bipolar Disorder and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antidepressant-augmentation","display_name":"antidepressant augmentation","score":0.8100000023841858},{"id":"https://openalex.org/keywords/treatment-resistant-depression","display_name":"treatment-resistant depression","score":0.8109999895095825},{"id":"https://openalex.org/keywords/lithium-augmentation","display_name":"lithium augmentation","score":0.8399999737739563},{"id":"https://openalex.org/keywords/buspirone","display_name":"buspirone","score":0.8999999761581421},{"id":"https://openalex.org/keywords/methylphenidate","display_name":"methylphenidate","score":0.9399999976158142},{"id":"https://openalex.org/keywords/modafinil","display_name":"modafinil","score":0.9760000109672546},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9929999709129333},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9449999928474426},{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.9929999709129333},{"id":"https://openalex.org/keywords/aripiprazole","display_name":"aripiprazole","score":0.9739999771118164},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9990000128746033},{"id":"https://openalex.org/keywords/yohimbine","display_name":"yohimbine","score":0.8889999985694885},{"id":"https://openalex.org/keywords/atomoxetine","display_name":"atomoxetine","score":0.9800000190734863},{"id":"https://openalex.org/keywords/myo-inositol","display_name":"myo-inositol","score":0.9700000286102295},{"id":"https://openalex.org/keywords/testosterone","display_name":"testosterone","score":0.8999999761581421},{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9300000071525574},{"id":"https://openalex.org/keywords/mirtazapine","display_name":"mirtazapine","score":0.8539999723434448},{"id":"https://openalex.org/keywords/desipramine","display_name":"desipramine","score":0.8629999756813049},{"id":"https://openalex.org/keywords/mianserin","display_name":"mianserin","score":0.8149999976158142},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5770000219345093},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5329999923706055}],"concepts":[{"id":"https://openalex.org/C2778781522","wikidata":"https://www.wikidata.org/wiki/Q417240","display_name":"Atomoxetine","level":4,"score":0.6306800246238708},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6286850571632385},{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.5962731242179871},{"id":"https://openalex.org/C2780211496","wikidata":"https://www.wikidata.org/wiki/Q411188","display_name":"Aripiprazole","level":3,"score":0.5669951438903809},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5177704095840454},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.49670296907424927},{"id":"https://openalex.org/C2779583969","wikidata":"https://www.wikidata.org/wiki/Q423757","display_name":"Escitalopram","level":4,"score":0.472406804561615},{"id":"https://openalex.org/C2777112843","wikidata":"https://www.wikidata.org/wiki/Q422112","display_name":"Methylphenidate","level":3,"score":0.4617351293563843},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.4611622989177704},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.45538946986198425},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.4525345265865326},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4497881531715393},{"id":"https://openalex.org/C2779908668","wikidata":"https://www.wikidata.org/wiki/Q834280","display_name":"Bupropion","level":3,"score":0.4252721071243286},{"id":"https://openalex.org/C2780831388","wikidata":"https://www.wikidata.org/wiki/Q416701","display_name":"Mianserin","level":4,"score":0.4126838445663452},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.38201379776000977},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34380394220352173},{"id":"https://openalex.org/C2780783007","wikidata":"https://www.wikidata.org/wiki/Q181923","display_name":"Attention deficit hyperactivity disorder","level":2,"score":0.29142239689826965},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.14365410804748535},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.1310766339302063},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.11328181624412537},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C2777843972","wikidata":"https://www.wikidata.org/wiki/Q2462253","display_name":"Smoking cessation","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.64719/pb.4089","doi":"https://doi.org/10.64719/pb.4089","is_oa":false,"landing_page_url":"https://doi.org/10.64719/pb.4089","pdf_url":null,"source":{"id":"https://openalex.org/S5407052355","display_name":"Psychopharmacology Bulletin","issn_l":"0048-5764","issn":["0048-5764","2472-2448"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["medline","poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology Bulletin","raw_type":"journal-article"},{"id":"pmid:19752841","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19752841","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Psychopharmacology bulletin","raw_type":"Journal Article"},{"id":"mag:1854929367","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19752841","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2046017746","https://openalex.org/W3153000881","https://openalex.org/W2069840329","https://openalex.org/W2147860479","https://openalex.org/W1991552243","https://openalex.org/W7116336308","https://openalex.org/W2073484627","https://openalex.org/W2055884125","https://openalex.org/W7171766877","https://openalex.org/W4252843122"],"abstract_inverted_index":{"Major":[0],"depressive":[1,237],"disorder":[2,238],"(MDD)":[3],"is":[4,160],"a":[5,92],"leading":[6],"cause":[7],"of":[8,33,46,103,123,145,169,180,218,230],"disability":[9],"worldwide.":[10],"Clinicians":[11],"need":[12,225],"to":[13,163,173,205,226,243],"determine":[14],"the":[15,34,53,170,212,219],"most":[16],"appropriate":[17],"and":[18,67,69,75,87,97,118,127,197,216],"effective":[19],"interventions":[20],"for":[21,39],"patients":[22,154,234],"who":[23,239],"do":[24,240],"not":[25,241],"benefit":[26],"from":[27],"first-line":[28],"treatment.":[29],"A":[30,44],"systematic":[31],"review":[32],"literature":[35],"on":[36],"augmentation":[37,57,81,111,129,147,231],"strategies":[38,58,82],"major":[40,236],"depression":[41],"was":[42,100,148],"conducted.":[43],"total":[45],"32":[47],"eligible":[48,143],"studies":[49,78,122],"were":[50,137],"included":[51,59],"in":[52,110,233],"final":[54],"review.":[55],"Identified":[56],"lithium,":[60],"thyroid":[61,146],"hormone,":[62],"buspirone,":[63,113],"stimulant":[64],"drugs":[65],"(methylphenidate":[66],"modafinil),":[68],"atypical":[70,187,220],"antipsychotics":[71,188],"(olanzapine,":[72],"quetiapine,":[73],"aripiprazole,":[74],"risperidone).":[76],"Additional":[77],"used":[79],"other":[80],"(yohimbine,":[83],"atomoxetine,":[84],"inositol,":[85,117],"testosterone,":[86,114],"lamotrigine),":[88],"or":[89],"combinations":[90],"with":[91,112,156,186,194,211,235],"second":[93],"antidepressant":[94,125,195],"(mianserin,":[95],"mirtazapine,":[96],"desipramine).":[98],"There":[99],"no":[101],"evidence":[102],"clinical":[104,134],"efficacy":[105],"as":[106],"measured":[107],"by":[108],"response":[109,191],"methylphenidate,":[115],"yohimbine,":[116],"atomoxetine.":[119],"Although":[120],"some":[121,168],"combined":[124],"therapy":[126,185,232],"lithium":[128],"did":[130],"show":[131],"statistically":[132],"significant":[133,175],"effects,":[135],"results":[136],"inconsistent":[138],"across":[139],"studies.":[140],"The":[141],"only":[142],"study":[144,152],"positive,":[149],"though":[150],"this":[151],"evaluated":[153],"treated":[155],"tricyclic":[157],"antidepressants.":[158],"It":[159],"possible":[161],"due":[162,204],"small":[164],"sample":[165],"sizes,":[166],"that":[167],"trials":[171],"failed":[172],"detect":[174],"differences":[176],"versus":[177],"placebo":[178,198],"because":[179],"inadequate":[181],"statistical":[182],"power.":[183],"Adjunctive":[184],"showed":[189],"higher":[190],"rates":[192],"compared":[193],"monotherapy":[196],"but":[199],"also":[200],"had":[201],"more":[202],"withdrawals":[203],"adverse":[206],"events.":[207],"Given":[208],"ongoing":[209],"concerns":[210],"longer":[213],"term":[214],"tolerability":[215],"safety":[217],"antipsychotics,":[221],"future":[222],"research":[223],"will":[224],"investigate":[227],"optimal":[228],"duration":[229],"respond":[242],"first":[244],"line":[245],"therapy.":[246]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}